Forecasting

Forecasting for pipeline products

Andrew Tolve — Wed, 01 Sep 2010 09:42:31 +0100

Dennis Van Liew, senior director and site head for strategic management at Sandwich Laboratories, Pfizer EU, on why commercial and research teams should work together to forecast the commercial potential of pipeline products.

Forecasting opportunities in the Middle Eastern market

Editor — Wed, 01 Sep 2010 09:38:33 +0100

Radi Haloub, researcher, University of Huddersfield and former area sales manager for Hikma Pharmaceuticals, talks to eyeforpharma about the evolution of the pharma market in the Middle East.

Best practice in modeling and forecasting

Editor — Wed, 01 Sep 2010 09:34:57 +0100

Todd Johnson, director of forecasting, Kantar Health, and Lee Blansett, senior vice president, oncology market access, Kantar Health, talk to eyeforpharma about European and US strategies to control spending and manage budgets; David Robinson, Kantar Health’s senior director of epidemiology services, discusses the utility of epidemiological analyses of complex diseases.

Biomarkers and oncology forecasting: How to hit a moving target

Peter Mansell — Tue, 03 Aug 2010 15:15:43 +0100

Peter Mansell investigates why biomarkers and other molecular diagnostic tools may be the most undervalued area in oncology

Forecasting: Patient flow modeling comes of age

Editor — Tue, 03 Aug 2010 14:47:38 +0100

Judith Kulich, associate principal, and Emily Jin, manager, at ZS Associates talk to eyeforpharma about how patient flow modeling can inform forecasting

Understanding the utility of MPR

Editor — Tue, 03 Aug 2010 14:17:53 +0100

Kevin Cast, vice president, Curascript, explains how medication possession ratios (MPR) can improve forecasting and compliance

Forecasting for ‘pharmerging’ markets

Peter Mansell — Thu, 08 Jul 2010 11:00:34 +0100

Peter Mansell explores why new forecasting models and methods are needed as pharmaceutical companies increasingly turn to emerging markets to offset faltering growth.

Forecasting for orphan drugs: The data challenge

Angelo DePalma — Thu, 08 Jul 2010 10:57:26 +0100

Gianclaudio Floria, senior manager for business planning and analysis at Amgen, on best practice in forecasting for orphan drug development.

Forecasting for complex diseases

Peter Mansell — Tue, 08 Jun 2010 12:27:04 +0100

Peter Mansell reports on how advances in molecular and cell biology are making the forecaster’s job more complex—and more business critical.

Forecasting: Does Wall St know something pharma doesn't?

Andrew Tolve — Tue, 08 Jun 2010 12:23:23 +0100

Andrew Tolve explores how pharma forecasters and Wall St analysts can improve their forecasts by learning from each other.